Skip to main content

Animations

MJFF Publications

6711 - 6720 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2025
  • 2019
  • 2022
  • 2020
  • 2024
  • 2016
  • 2015
  • 2025
  • 2014
  • Summary Details
    OPEN
    Title: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy
    Journal Name: SLAS Discovery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004
    Citation Count: 11
  • Summary Details
    OPEN
    Title: A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43587-025-00926-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci.insight.126769
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Deep learning architectures for Parkinson's disease detection by using multi-modal features
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2022.105610
    Citation Count: 36
  • Summary Details
    OPEN
    Title: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-15626-w
    Citation Count: 341
  • Summary Details
    RESTRICTED
    Title: α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00816-w
    Citation Count: 3
  • Summary Details
    OPEN
    Title: TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.19809
    Citation Count: 122
  • Summary Details
    OPEN
    Title: Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
    Journal Name: Neuropathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/neup.12189
    Citation Count: 427
  • Summary Details
    OPEN
    Title: Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2025.101999
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Systematic Optimization of Long Gradient Chromatography Mass Spectrometry for Deep Analysis of Brain Proteome
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1021/pr500882h
    Citation Count: 92
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.